0000899243-23-010755.txt : 20230405
0000899243-23-010755.hdr.sgml : 20230405
20230405164809
ACCESSION NUMBER: 0000899243-23-010755
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230307
FILED AS OF DATE: 20230405
DATE AS OF CHANGE: 20230405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reese Lou
CENTRAL INDEX KEY: 0001890674
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 23803201
MAIL ADDRESS:
STREET 1: C/O VAXXINITY, INC.
STREET 2: 1717 MAIN ST STE. 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-07
0
0001851657
Vaxxinity, Inc.
VAXX
0001890674
Reese Lou
C/O VAXXINITY, INC.
505 ODYSSEY WAY
MERRITT ISLAND
FL
32953
1
1
0
0
See Remarks
0
Stock Option (right to buy)
2.29
2023-03-07
4
A
0
620000
0.00
A
2033-03-07
Class A Common Stock
620000
620000
D
Stock Option (right to buy)
2.29
2023-03-07
4
A
0
61607
0.00
A
2033-03-07
Class A Common Stock
61607
61607
D
Stock Option (right to buy)
2.29
2023-03-07
4
A
0
301188
0.00
A
2033-03-07
Class A Common Stock
301188
301188
D
The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.
The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options are fully vested upon issuance. This one-time option grant was made in lieu of an annual cash bonus payment to Mr. Reese.
The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 12 equal monthly installments beginning on January 1, 2023. The one-time option grant was made in consideration of Mr. Reese waiving his salary for fiscal years 2022 and 2023.
Executive Chairman.
/s/ Rene Paula Molina as Attorney-in-Fact for Lou Reese
2023-04-05